The four-month-old is now waiting one hundred days to find out if the transplant was a success.

Of the 27 refractory patients treated in the study, 82% had a genetically confirmed primary HLH diagnosis. The most common adverse reactions reported during the study were infections (56% ...

Emapalumab-Izsg is under the FDA’s Priority Review for hemophagocytic lymphohistiocytosis/macrophage activation syndrome in Still disease.

were old their daughter has hemophagocytic lymphohistiocystosis (HLH). Following the diagnosis, Dolcie-Mae was airlifted to the Royal Victoria Infirmary in Newcastle from her home in South Wales ...